Alkermes (ALKS) has made an impressive comeback, thanks to the new products and expertise that came with last year's merger with Elan Drug Technologies There's nothing like the launch of a blockbuster drug to fuel a biotech outfit's growth engine. Add to that an emerging product pipeline and a transformational merger and you have the prescription that's helping to nurse…